Compass Therapeutics (CMPX) Earnings Analysis
Compass Therapeutics (CMPX) next reports earnings on 2026-08-10, consensus EPS -0.1 USD. Last quarter (2026-03-05) it beat with EPS -0.09 USD vs -0.1 USD est (+10%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -4.80.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CMPX next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.1 USD |
| Revenue estimate | -0.00B |
CMPX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | -0.09 USD | -0.1 USD | +10% | Beat |
| 2025-08-11 | -0.14 USD | -0.13 USD | -7.7% | Miss |
| 2025-02-27 | -0.11 USD | -0.1 USD | -10% | Miss |
| 2024-08-12 | -0.1 USD | -0.1 USD | 0% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
CMPX valuation and analyst view
| Trailing P/E | -4.80 |
|---|---|
| Trailing EPS | -0.36573 USD |
| Price / book | 2.04 |
| Dividend yield | 0.00% |
| Market cap | 0.28B |
| Analyst consensus | Buy (15 buy / 0 hold / 0 sell) |
| Avg price target | 6 USD |
Related research pages
Frequently asked questions
When is Compass Therapeutics (CMPX)'s next earnings date?
Compass Therapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.1 USD and revenue estimate of -0.00B.
Did CMPX beat earnings last quarter?
In its 2026-03-05 report, CMPX posted EPS of -0.09 USD versus a -0.1 USD estimate — a beat of 10%.
What is CMPX's earnings track record?
Over the last 4 reported quarters with consensus data, CMPX beat estimates 2 times (50%).
What is CMPX's current P/E ratio and EPS?
CMPX trades at a trailing P/E of -4.80 on trailing EPS of -0.3657349785407725 USD.
What do analysts rate CMPX?
Analyst consensus is "Buy" across 15 ratings (0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 6 USD.